Press Releases

Date Description  
Nov 25, 2014
GERD Awareness Week Puts the Focus on Patient-Centric Diagnostics

Vision-Sciences' EndoSheath(R) Transnasal Esophagoscopy System Offers Simple, Safe Visual Exams for GERD Patients

Nov 5, 2014
Vision-Sciences Reports Financial Results of Second Quarter and First Half Fiscal 2015
ORANGEBURG, N.Y., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath ® technology, today announced financial results for the second quarter and first six months
Nov 4, 2014
Study Reveals Endoscopes May Be Susceptible to Inadequate Sterilization Despite Following Reprocessing Guidelines

Vision-Sciences EndoSheath(R) Technology Offers a Sterile, Single-Use Solution for Endoscopic Procedures

Oct 27, 2014
Vision-Sciences TNE System Offers Solution for Sedation Concerns
A Simple Procedure and Novel Technology Provide an Alternative to Sedated Esophageal Exams ORANGEBURG, N.Y., Oct. 27, 2014 (GLOBE NEWSWIRE) -- The report by the New York City Office of the Chief Medical Examiner on the death of Joan Rivers points to a "predictable complication of medical therapy."
Oct 1, 2014
Vision-Sciences Announces CE Mark and European Launch of Next Generation EndoSheath® Bronchoscopy System

<i>The BRS-5100 Model Offers Improved Ease of Use and Cost Savings for Hospitals</i>

Sep 22, 2014
Vision-Sciences Introduces Smallest Diameter Flexible Video Laryngoscope to the Ear-Nose-and Throat Market
The ENT-7000 Offers High Resolution Imaging and Maximum Patient Comfort for Ear Nose and Throat Diagnostics ORANGEBURG, N.Y. , Sept. 22, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile
Aug 4, 2014
Vision-Sciences Reports First Quarter Fiscal 2015 Results
ORANGEBURG, N.Y., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath ® technology, today announced financial results for the first quarter of fiscal 2015, ended
May 19, 2014
Vision-Sciences Introduces Next Generation, EndoSheath® Bronchoscopy System

The BRS-5100 Model Offers Improved Ease of Use, Patient Safety Features, and Cost Savings for Hospitals

Apr 28, 2014
Vision-Sciences Announces Record Revenues of $5.0 Million for Fourth Quarter and $17.1 Million for Full Year Fiscal 2014
ORANGEBURG, N.Y., April 28, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath ® technology, today announced financial results for the fourth quarter and full year
Apr 21, 2014
Vision-Sciences to Host Fourth Quarter and Full Year Fiscal 2014 Results Call
ORANGEBURG, N.Y., April 21, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the
Displaying 61 - 70 of 74